United States· US:0006-5028_13b78d9a-fa62-4fcf-8a33-233bc48faccb
VERQUVO
A vericiguat product containing vericiguat, registered in United States by Merck Sharp & Dohme LLC. The same ATC class is registered in 15 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Vericiguat is registered in 15 of 19 countries.
Countries holding a registration under ATC C01DX22 (vericiguat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Vericiguat · ATC C01DX22
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vericiguat costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vericiguat · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$12.83
- ES Spain$9.99
- IT Italy$9.50
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- VERICIGUAT
- Manufacturer
- Merck Sharp & Dohme LLC
- Country
- United States (US)
- ATC code
- C01DX22
- ATC class
- Vericiguat
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc11000650280114 TABLET, FILM COATED in 1 BOTTLE (0006-5028-01)
- ndc11000650280230 TABLET, FILM COATED in 1 BOTTLE (0006-5028-02)
- ndc11000650280410 BLISTER PACK in 1 CARTON (0006-5028-04) / 10 TABLET, FILM COATED in 1 BLISTER PACK (0006-5028-03)
- ndc1100065028061 BOTTLE in 1 CARTON (0006-5028-06) / 14 TABLET, FILM COATED in 1 BOTTLE (0006-5028-05)
- ndc110006-5028-01
- ndc110006-5028-02
- ndc110006-5028-04
- ndc110006-5028-06
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vericiguat in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVERQUVOBayer AG, Leverkusen
- SwitzerlandVerquvo 2.5 mg, FilmtablettenBayer (Schweiz) AG
- SpainVERQUVO 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULABayer Ag
- FinlandVerquvoBayer AG
- IrelandVerquvo 2.5 mg film-coated tabletsBayer AG
- IcelandVerquvoBayer AG*
- NetherlandsVerquvo 2,5 mg filmomhulde tablettenBayer AG
- NorwayVerquvoBayer AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Verquvo
- Liechtenstein · Verquvo
- Norway · Verquvo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4c634dcd-340a-4a1e-a52f-67bc54bc7e25 GET /v1/drugs/4c634dcd-340a-4a1e-a52f-67bc54bc7e25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2.5",
"substance": "VERICIGUAT",
"productndc": "0006-5028",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA214377",
"marketing_category": "NDA"
}See everything about vericiguat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.